Moderna is a US biotechnology company with headquarters in Cambridge, Massachusetts. Learn the latest information and analysis on the company, MRNA stock price today, stock news, how much one share costs and other information to help you make investment decisions.
Check out Gainy to see insights on stock prices and more.
Moderna’s main focus is on RNA therapeutics, primarily mRNA vaccines. The company came to prominence recently due to the Covid pandemic, when its vaccine became one of the first to be approved for emergency use on the population.
Despite huge sales of its Covid vaccine, the majority of the company’s revenue (60%) comes from grants. It has partnerships with key players in the industry, such as AstraZeneca, Merck, and Vertex. MRNA is one of the biggest biotech stocks with a market cap of $54 billion.
The Moderna stock price went from around $20 to $150 in 2020 and kept growing into 2021, closing at $484.47 on August 9. It has been falling since then, reaching a price of $135 (as of 5/10/22), which could be a good buying opportunity.
Check back to this page for the MRNA stock quote or download Gainy to see if MRNA fits your portfolio and investment goals, as well as other stock quotes and recommendations that fit your portfolio and interests.
